Molecular nociceptive mechanisms in migraine: The migraine cascade
European Journal of Neurology · 2024-08 · 31 (8)
DOI: 10.1111/ene.16333 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Neurology, online erschienen am 18.06.2024. Verfasst von Song Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Danish Headache Center, Department of Neurology, Translational Research Center, Rigshospitalet-Glostrup, Faculty of Health and Medical Sciences, Univ…. Hauptthemen laut MEDLINE: Migraine Disorders, Pituitary Adenylate Cyclase-Activating Polypeptide, Nociception. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This review will explore the categorization of migraine‐provoking molecules, their cellular actions, site of action and potential drug targets based on the migraine cascade model.
Methods
Personal experience and literature.
Results
Migraine impacts over 1 billion people worldwide but is underfunded in research. Recent progress, particularly through the human and animal provocation model, has deepened our understanding of its mechanisms. This model have identified endogenous neuropeptides such as calcitonin gene‐related peptide (CGRP) and pituitary adenylate cyclase‐activating peptide (PACAP) that induces controlled migraine‐like attacks leading to significant discoveries of their role in migraine. This knowledge led to the development of CGRP‐inhibiting drugs; a groundbreaking migraine treatment now accessible globally. Also a PACAP‐inhibiting drug was effective in a recent phase II trial. Notably, rodent studies have shed light on pain pathways and the mechanisms of various migraine‐inducing substances identifying novel drug targets. This is primarily done by using selective inhibitors that target specific signaling pathways of the known migraine triggers leading to the hypothesized cellular cascade model of migraine.
Conclusion
The model of migraine presents numerous opportunities for innovative drug development. The future of new migraine treatments is limited only by the investment from pharmaceutical companies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Danish Headache Center, Department of Neurology, Translational Research Center, Rigshospitalet-Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark.
- Department of Neurology, Zealand University Hospital, Roskilde, Denmark.
ORCID-Profile: Song Guo, Jes Olesen
Zitieren
APA
Guo, S., Christensen, S. L., Al-Karagholi, M. A., & Olesen, J. (2024). Molecular nociceptive mechanisms in migraine: The migraine cascade. European Journal of Neurology, 31(8). https://doi.org/10.1111/ene.16333
Vancouver
Guo S, Christensen SL, Al-Karagholi MA, Olesen J. Molecular nociceptive mechanisms in migraine: The migraine cascade. European Journal of Neurology. 2024;31(8). doi:10.1111/ene.16333
BibTeX
@article{Guo2024,
author = {Guo, Song and Christensen, Sarah Louise and Al-Karagholi, Mohammad Al-Mahdi and Olesen, Jes},
title = {Molecular nociceptive mechanisms in migraine: The migraine cascade},
journal = {European Journal of Neurology},
year = {2024},
volume = {31},
number = {8},
doi = {10.1111/ene.16333}
}
EUVIMED